Latest Period
n/a
Security Snapshot
AVENUE THERAPEUTICS, INC. - Common Stock (ATXI) Institutional Ownership
CUSIP: 05360L403
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.30
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ATXI on OTC
- Shares outstanding
- 3,190,732
- SEC-reported price per share
- $0.30
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ATXI - AVENUE THERAPEUTICS, INC. - Common Stock is tracked under CUSIP 05360L403.
- Latest finished 13F holder period is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 7 to 0 between Q4 2024 and Q1 2025.
- SEC-reported value moved from $385,256 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
05360L403
Latest holder period
n/a
13F holders
13D/G owners
3
CIK / CUSIP context first
ATXI full holder history
AVENUE THERAPEUTICS, INC. SEC filings
AVENUE THERAPEUTICS, INC. company facts
AVENUE THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05360L403:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
ATXI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 13% | +31% | $290,370 | +$73,398 | 439,955 | +34% | Fortress Biotech, Inc. | 02 Jan 2026 |
| Ikarian Capital, LLC | 4.1% | -39% | $86,341 | -$6,059 | 130,820 | -6.6% | Ikarian Capital, LLC | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 5% | $25,100 | 100,400 | Armistice Capital, LLC | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
n/a
Rows shown
1-4 of 4